Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) Debt to Equity: 2017-2021

Historic Debt to Equity for AC Immune (ACIU) over the last 4 years, with Dec 2021 value amounting to $0.09.

  • AC Immune's Debt to Equity was N/A to $0.09 in Q4 2021 from the same period last year, while for Dec 2021 it was $0.09, marking a year-over-year change of. This contributed to the annual value of $0.09 for FY2021, which is N/A change from last year.
  • Latest data reveals that AC Immune reported Debt to Equity of $0.09 as of Q4 2021, which was up 7,663.80% from -$0.00 recorded in Q3 2020.
  • Over the past 5 years, AC Immune's Debt to Equity peaked at $1.56 during Q2 2017, and registered a low of -$0.00 during Q3 2020.
  • Moreover, its 3-year median value for Debt to Equity was $0.00 (2019), whereas its average is $0.01.
  • Data for AC Immune's Debt to Equity shows a maximum YoY slumped of 152.25% (in 2020) over the last 5 years.
  • Over the past 5 years, AC Immune's Debt to Equity (Quarterly) stood at $0.00 in 2017, then plummeted by 31.03% to $0.00 in 2018, then dropped by 17.94% to $0.00 in 2019, then slumped by 152.25% to -$0.00 in 2020, then reached $0.09 in 2021.
  • Its Debt to Equity stands at $0.09 for Q4 2021, versus -$0.00 for Q3 2020 and -$0.00 for Q2 2020.